EFSD New Targets for Diabetes or Obesity-related Metabolic Diseases

Funding to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes or obesity-related metabolic diseases.

The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

The EFSD European Research Programme on ‘New Targets for Diabetes or Obesity-related Metabolic Diseases’ is intended to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes or obesity-related metabolic diseases. The Programme is supported by an educational research grant from Merck Sharpe & Dohme (MSD).

Proposals may include but are not limited to:

• Mechanisms to induce ‘browning of adipose tissue’.
• New targets for improving skeletal muscle or adipose tissue insulin resistance.
• Bile acid biology as it relates to metabolic disease. This includes actions relating to glucose metabolism, lipid metabolism, energy balance and related diseases including diabetes, atherosclerosis and obesity.
• The role of lipid droplets in the aetiology of metabolic fatty liver disease.
• Mechanisms of glucose-dependent insulin and glucagon secretion.